MST1R and nasopharyngeal carcinoma: Patients with macrophage-stimulating 1 receptor (MST1R) germline mutations have been observed to be at a significantly higher risk of developing early age–onset NPC, suggesting that macrophage migration and phagocytic activity could be important protective processes.